Skip to content

examination of effectiveness and safety for robot-assisted laparoscopic radical hysterectomy (RALRH) for the patient with uterine cervical cancer

examination of effectiveness and safety for robot-assisted laparoscopic radical hysterectomy (RALRH) for the patient with uterine cervical cancer - examination of RALRH for uterine cervical cancer

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018300
Enrollment
10
Registered
2015-07-15
Start date
2015-08-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

uterine cervical cancer

Interventions

We perform robot-assisted laparoscopic radical hysterectomhy for the patient with uterin cervical cancer.

Sponsors

Shiga medical university hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Uterine cervical cancer, stage IA2-IIB (FIGO criteria) Generally good status (Performance status 0-2) Be agreed by the patient

Exclusion criteria

Exclusion criteria: The condition of having severe complecation (for example coronary heart disease,arrythmia,diabetes,liver failure,renal failure,glaucoma)Possibility of infection Judged unsuitable by researchers

Design outcomes

Primary

MeasureTime frame
blood loss

Secondary

MeasureTime frame
operative time consol time number of resected lymphnodes appropriateness of resected organ rate of transfusion urinary function complications

Countries

Japan

Contacts

Public ContactTsukuru Amano

Shiga medical university obstetrics and gynecology

tsukuru@belle.shiga-med.ac.jp0775482267

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026